Literature DB >> 35963978

Injection of freshly collected autologous adipose tissue in complicated pilonidal disease: a prospective pilot study.

Vestergaard G Sophie1, Sørensen J Marlene2, Hougaard T Helene3, Lundby Lilli3, Pedersen G Allan4, Haas Susanne5.   

Abstract

BACKGROUND: Pilonidal sinus disease (PSD) is a frequent disorder. Treatment failure and recurrence are common, leading to significant morbidity. The aim of this study was to investigate the impact and need for repeated treatment of injected autologous adipose tissue into non-healing PSD wounds and primary anal-near PSD or anal-near recurrence.
METHODS: At the Department of Surgery, Randers Regional Hospital, Denmark, a prospective pilot study was conducted on consecutive PSD patients with lack of healing 3 months after surgery (Bascom's cleft lift) or with primary or recurrent anal-near pilonidal sinus disease from December 2018 to March 2020. The primary endpoint was time to healing. Autologous adipose tissue was harvested from the patients and injected into the lesions after surgical revision. Patients were examined 2 and 12 weeks after surgery. Patients with lack of healing after 12 weeks (undermining or no skin coverage) were offered re-injection.
RESULTS: We included 30 patients [26 men and 4 women, median age 24 years (range 18-59 years)]. Complete healing was achieved in 25 patients [83.3%; 95% CI (69.9-96.7)]. Two patients had recurrence (6.7%). The median time to complete healing was 159 (189) days. The mean operation time was 70.6 ± 23.7 min and the mean amount of injected autologous adipose tissue was 19 ± 10 ml. There were no major complications.
CONCLUSION: Freshly collected autologous adipose tissue injected into chronic non-healing or primary and recurrent PSD lesions near the anal verge is safe and efficient.
© 2022. Springer Nature Switzerland AG.

Entities:  

Keywords:  Adipose tissue-derived stem cells; Autologous fat injection; Autologous stem cells; Non-healing wound; Pilonidal disease; Recurrent pilonidal disease

Mesh:

Year:  2022        PMID: 35963978     DOI: 10.1007/s10151-022-02683-0

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.699


  6 in total

1.  [Trends in incidence and long-term recurrence rate of pilonidal sinus disease and analysis of associated influencing factors].

Authors:  Theo Evers; Dietrich Doll; Edouard Matevossian; Sebastian Noe; Konrad Neumann; Hui-li Li; Norbert Hüser; Rainer Lüdde; Sebastian Hoffmann; Björn Dirk Krapohl
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2011-09-01

Review 2.  Topical Agents and Dressings for Pilonidal Sinus Wound Healing by Secondary Intention: A Scoping Review.

Authors:  Kevin Y Woo; Enid Wai-Yung Kwong; Carolina Jimenez; Richard Bishop
Journal:  Surg Technol Int       Date:  2015-05

3.  Pilonidal disease: origin from follicles of hairs and results of follicle removal as treatment.

Authors:  J Bascom
Journal:  Surgery       Date:  1980-05       Impact factor: 3.982

Review 4.  Nutrition support in hospitalised adults at nutritional risk.

Authors:  Joshua Feinberg; Emil Eik Nielsen; Steven Kwasi Korang; Kirstine Halberg Engell; Marie Skøtt Nielsen; Kang Zhang; Maria Didriksen; Lisbeth Lund; Niklas Lindahl; Sara Hallum; Ning Liang; Wenjing Xiong; Xuemei Yang; Pernille Brunsgaard; Alexandre Garioud; Sanam Safi; Jane Lindschou; Jens Kondrup; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2017-05-19

Review 5.  The Management of Pilonidal Sinus.

Authors:  Igors Iesalnieks; Andreas Ommer
Journal:  Dtsch Arztebl Int       Date:  2019-01-07       Impact factor: 5.594

Review 6.  Healing by primary versus secondary intention after surgical treatment for pilonidal sinus.

Authors:  Ahmed Al-Khamis; Iain McCallum; Peter M King; Julie Bruce
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.